How long should we treat patients with azathioprine/ 6-mercaptopurine before deciding that it is refractory to immunomodulatory treatment?
(Turk J Gastroenterol 2012; 23: 13-16)
Can azathioprine/6-mercaptopurine treatment be withdrawn in patients with response in ulcerative colitis: What is the most appropriate time for this?
(Turk J Gastroenterol 2012; 23: 17-20)
What is the importance of anti-TNF agents in the treatment of luminal (inflammatory type) Crohn's disease?
(Turk J Gastroenterol 2010; 21: 107-112)
Effects of polymorphism in G2677T/A triallelic region of MDR1 gene in Turkish patients with inflammatory bowel disease
(Turk J Gastroenterol 2008; 19: 168-173)
The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: A pilot study
(Turk J Gastroenterol 2004; 15: 225-228)
Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease
(Turk J Gastroenterol 2004; 15: 250-252)
Two relatives with Caroli’s disease
(Turk J Gastroenterol 2001; 12: 69-71)
Serum connective tissue markers as predictors of advanced fibrosis in patients with chronic hepatitis B and D
(Turk J Gastroenterol 2011; 22: 305-314)
Diagnosis and treatment of iron deficiency anemia in patients with inflammatory bowel disease and gastrointestinal bleeding: iron deficiency anemia working group consensus report
(Turk J Gastroenterol 2017; 28: 81-87)
Association between single nucleotide polymorphisms in prospective genes and susceptibility to ankylosing spondylitis and inflammatory bowel disease in a single centre in Turkey
(Turk J Gastroenterol 2016; 27: 317-324)